Cargando…
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102691/ https://www.ncbi.nlm.nih.gov/pubmed/27899953 http://dx.doi.org/10.3332/ecancer.2016.680 |